APA (7th ed.) Citation

R, U., U, B., S, S., G, B., PW, C., P, D. C., & N, W. (2019). Erratum to "Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects". Journal of obesity, 2019, 6189724. https://doi.org/10.1155/2019/6189724

Chicago Style (17th ed.) Citation

R, Uebelhack, Bongartz U, Seibt S, Bothe G, Chong PW, De Costa P, and Wszelaki N. "Erratum to "Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects"." Journal of Obesity 2019 (2019): 6189724. https://doi.org/10.1155/2019/6189724.

MLA (9th ed.) Citation

R, Uebelhack, et al. "Erratum to "Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects"." Journal of Obesity, vol. 2019, 2019, p. 6189724, https://doi.org/10.1155/2019/6189724.